Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder.
The co-morbidity between attention deficit hyperactivity disorder (ADHD) and substance abuse and dependence disorders may have multiple causes and consequences. In this review, we will describe neurobehavioral, genetic and animal model studies that support the notion that a common, genetically determined failure of response inhibition function is an endophenotype for both disorders. Through an impairment in the ability to cognitively control pre-potent behaviors, subjects can exhibit a collection of ADHD-like traits (impulsivity and hyperactivity), as well as susceptibility for the initiation of drug taking and its ultimate progression to an inflexible, uncontrollable form. At the neural level, dysfunction within circuitry that includes the ventrolateral frontal and cingulate cortices, as well as in associated basal ganglia zones, contributes to a common pattern of behavioral impairment, explaining aspects of co-morbidity. Animal models of substance abuse/dependence and ADHD that exhibit deficits in response inhibition have substantiated the role of this endophenotype in both disorders and their co-morbidity and should provide a testing ground for interventions targeting it. New directions for research that will further explore this hypothesis and begin to reveal the underlying biological mechanisms will be proposed.
Groman
Stephanie M
SM
Department of Psychology, University of California at Los Angeles, CA 90095-1563, USA.
James
Alex S
AS
Jentsch
J David
JD
D000818:Animals; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications* / Q000235:genetics / Q000503:physiopathology*; D001479:Basal Ganglia / Q000503:physiopathology; D002540:Cerebral Cortex / Q000503:physiopathology; D003071:Cognition / Q000502:physiology; D004195:Disease Models, Animal; D005625:Frontal Lobe / Q000503:physiopathology; D006801:Humans; D007175:Impulsive Behavior / Q000235:genetics / Q000503:physiopathology; D008959:Models, Neurological; D019966:Substance-Related Disorders / Q000150:complications* / Q000235:genetics / Q000503:physiopathology*
Mol Psychiatry. 1997 Jul;2(4):311-3
9246671
Neuropsychopharmacology. 2002 Feb;26(2):183-90
11790514
Biol Psychiatry. 2008 Mar 1;63(5):439-40
18267152
Learn Mem. 2007 Apr 27;14(5):325-8
17522022
Am J Psychiatry. 2008 May;165(5):597-603
18316421
Biol Psychiatry. 2005 Jun 1;57(11):1313-23
15950004
Neurobiol Learn Mem. 2006 May;85(3):283-8
16423542
Psychopharmacology (Berl). 2000 Nov;152(4):362-75
11140328
J Addict Dis. 2004;23(4):31-40
15339712
Annu Rev Psychol. 2003;54:25-53
12185211
Life Sci. 2005 Jun 24;77(6):693-706
15922000
Biol Psychiatry. 2007 Jun 15;61(12):1340-50
17054922
Am J Med Genet. 2001 Jul 8;105(5):471-8
11449401
Am J Psychiatry. 2005 Aug;162(8):1515-20
16055774
J Clin Psychiatry. 2006;67 Suppl 8:7-12
16961424
Am J Psychiatry. 2001 Mar;158(3):486-9
11229995
Psychopharmacology (Berl). 2005 Mar;178(2-3):193-201
15338104
Neurosci Biobehav Rev. 2000 Jan;24(1):31-9
10654658
Am J Psychiatry. 2003 Nov;160(11):1909-18
14594733
Drug Alcohol Depend. 2005 Aug 1;79(2):273-7
15967595
Neuroimage. 2003 Jul;19(3):1095-102
12880835
Biol Psychiatry. 2007 Jun 15;61(12):1395-401
17046725
Biol Psychiatry. 2005 Jan 15;57(2):120-5
15652869
Biol Psychiatry. 2006 Nov 15;60(10):1111-20
16806100
Nat Rev Neurosci. 2002 Aug;3(8):617-28
12154363
Biol Psychiatry. 2003 Dec 15;54(12):1338-44
14675797
Behav Brain Res. 2005 Jul 1;162(1):47-61
15922066
Biol Psychiatry. 2008 Feb 1;63(3):301-8
17884016
Science. 1999 Jan 15;283(5400):397-401
9888856
Neuropsychopharmacology. 2008 Apr;33(5):1028-37
17637611
Am J Psychiatry. 1996 Mar;153(3):321-30
8610818
Neuropsychopharmacology. 2006 Nov;31(11):2376-83
16855530
Psychopharmacology (Berl). 2008 Apr;197(3):421-31
18214445
Neuropsychopharmacology. 2002 Nov;27(5):699-711
12431845
Drug Alcohol Depend. 2002 May 1;66(3):265-73
12062461
J Neurosci. 2007 Jan 3;27(1):245-50
17202492
Behav Brain Funct. 2006 Mar 28;2:10
16569223
J Abnorm Child Psychol. 1995 Aug;23(4):411-37
7560554
Neurobiol Dis. 2007 Jan;25(1):206-16
17064920
Psychopharmacology (Berl). 2007 Jun;192(2):171-82
17265075
Behav Neurosci. 2007 Jun;121(3):543-9
17592945
Biol Psychiatry. 2003 Dec 15;54(12):1465-8
14675812
Addict Biol. 2007 Jun;12(2):221-6
17508996
J Psychopharmacol. 2006 Jan;20(1):24-32
16174667
Mol Psychiatry. 2005 Jul;10(7):686-98
15809660
Metab Brain Dis. 2000 Dec;15(4):297-304
11383554
Biol Psychiatry. 2008 Jan 15;63(2):184-90
17707348
J Cogn Neurosci. 1997 Nov;9(6):835-47
23964603
J Neurosci. 1998 Aug 1;18(15):5901-7
9671677
J Abnorm Psychol. 2004 Nov;113(4):614-25
15535793
Neurosci Biobehav Rev. 2000 Jan;24(1):21-5
10654656
Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):310-7
17192955
Neuropsychopharmacology. 2007 Oct;32(10):2125-34
17299511
Neuroimage. 2008 Jul 1;41(3):718-27
18424180
J Neurosci. 2004 Jun 30;24(26):6028-36
15229250
J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):468-75
16601652
Science. 1989 Sep 29;245(4925):1511-3
2781295
Biol Psychiatry. 2005 Jun 1;57(11):1285-92
15950000
Nat Neurosci. 2006 Aug;9(8):1050-6
16829955
J Abnorm Child Psychol. 2003 Feb;31(1):105-20
12597703
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):34-41
17714843
Neuroreport. 2002 Dec 20;13(18):2453-7
12499848
Trends Genet. 2006 Jun;22(6):306-13
16697071
Pharmacol Biochem Behav. 2006 Sep;85(1):98-104
16904737
Pharmacol Biochem Behav. 2001 Apr;68(4):669-76
11526963
J Clin Psychiatry. 2006 Jan;67(1):148-59
16426101
Behav Brain Funct. 2005 Dec 15;1:24
16356184
BMC Psychiatry. 2005 Nov 01;5:40
16262903
Neurology. 2006 Sep 26;67(6):1023-7
17000972
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4552-7
16537431
J Neurosci. 2007 Dec 26;27(52):14358-64
18160643
J Neurosci. 2007 May 16;27(20):5506-14
17507572
Am J Psychiatry. 2001 Dec;158(12):2015-21
11729018
Psychopharmacology (Berl). 2009 Jan;202(1-3):505-19
18604598
Nat Neurosci. 2002 Jan;5(1):13-4
11731802
Behav Pharmacol. 1995 Dec;6(8):810-814
11224384
Psychiatr Clin North Am. 2004 Jun;27(2):283-301
15063998
Annu Rev Neurosci. 2001;24:167-202
11283309
Science. 2007 Mar 2;315(5816):1267-70
17332411
Biol Psychiatry. 2003 Jan 15;53(2):112-20
12547466
Psychol Bull. 1997 Jan;121(1):65-94
9000892
Behav Pharmacol. 2005 Feb;16(1):15-23
15706134
Am J Psychiatry. 1994 Dec;151(12):1791-6
7977887
J Neurosci. 2004 Dec 8;24(49):11017-22
15590917
Am J Psychiatry. 2003 Apr;160(4):636-45
12668349
Psychopharmacology (Berl). 2007 Jun;192(2):193-206
17277934
Psychopharmacology (Berl). 1999 Oct;146(4):373-90
10550488
Pharmacol Biochem Behav. 1999 Apr;62(4):719-25
10208378
Behav Brain Res. 2004 Mar 2;149(2):183-96
15129781
Neuroimaging Clin N Am. 2007 Nov;17(4):539-55, x
17983969
Arch Gen Psychiatry. 2004 Jan;61(1):73-84
14706946
J Child Psychol Psychiatry. 2005 Jul;46(7):774-803
15972070
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1982-7
11172062
Neuropsychopharmacology. 2001 Jan;24(1):66-74
11106877
Psychopharmacology (Berl). 1990;101(3):390-5
2362956
Ann N Y Acad Sci. 2004 Oct;1025:140-5
15542711
Eur J Neurosci. 2004 Apr;19(7):1997-2002
15078575
Psychopharmacology (Berl). 1987;91(4):458-66
3108926
J Neurosci. 1996 May 1;16(9):3104-11
8622140
Am J Psychiatry. 2005 May;162(5):906-13
15863792
Alcohol Clin Exp Res. 2006 Mar;30(3):429-37
16499483
J Abnorm Child Psychol. 1989 Oct;17(5):473-91
2681316
Psychopharmacology (Berl). 1999 Oct;146(4):432-9
10550493
Behav Brain Res. 2003 Dec 17;147(1-2):135-47
14659579
Am J Psychiatry. 2008 May;165(5):604-9
18381904
Behav Brain Res. 2000 Dec 20;117(1-2):69-74
11099759
Behav Brain Res. 2006 May 15;169(2):263-73
16500717
Biol Psychiatry. 2007 Nov 1;62(9):977-84
17644072
Braz J Med Biol Res. 2004 Oct;37(10):1511-7
15448872